Public Affairs: Featherstone joins Genzyme

A Lexington associate director has resigned after just four weeks to take the top lobbying role at healthcare firm Genzyme.

Henry Featherstone briefly led Lexington's healthcare division, but has left after being offered the job of head of public affairs at the Sanofi-owned company that develops therapies for genetic and serious debilitating diseases.

Featherstone joined Lexington from Fleishman-Hillard, where he was senior policy adviser for healthcare. Previously, he worked as head of health and social care at Policy Exchange. He has also worked as a junior doctor and was chief of staff to James Arbuthnot MP, chairman of the defence select committee.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in